The Effect of Hyoscine Butylbromide for Shortening the Active Phase of the First Stage of Labor: A randomized, double-blind, placebo-controlled trial
Thai Journal of Obstetrics and Gynaecology · 01.01.2024
DOI: 10.14456/tjog.2024.27 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thai Journal of Obstetrics and Gynaecology, erschienen am 01.01.2024. Verfasst von Jongruk Kamkong.
Abstract (Originalsprache)
Objectives
To study the efficacy and safety of hyoscine butylbromide for shortening the active phase of the first stage of labor.Materials and Methods: After receiving informed consent, singleton pregnant women who planned vaginal delivery at Khon Kaen Hospital between July 2022 and April 2023 were randomly allocated into two groups: the control group (n = 61) received 1 mL (20 mg) of intravascular hyoscine butylbromide, while the control group (n = 61) received 1 mL of intravascular normal saline at 5-6 cm cervical dilatation. The duration of the active phase of the first stage of labor and adverse events were analyzed.
Results
Baseline characteristics were not statistically different between groups. Hyoscine butylbromide significantly shortened the active phase of the first stage of labor compared to the control group (88.5 ± 66.7 min vs 188.5 ± 101.9 min, respectively, mean difference -100.02 min (95% confidence interval -130.72 to -69.31, p
Schlagwörter
Zitieren
APA
Kamkong, J. (2024). The Effect of Hyoscine Butylbromide for Shortening the Active Phase of the First Stage of Labor: A randomized, double-blind, placebo-controlled trial. Thai Journal of Obstetrics and Gynaecology. https://doi.org/10.14456/tjog.2024.27
Vancouver
Kamkong J. The Effect of Hyoscine Butylbromide for Shortening the Active Phase of the First Stage of Labor: A randomized, double-blind, placebo-controlled trial. Thai Journal of Obstetrics and Gynaecology. 2024. doi:10.14456/tjog.2024.27
BibTeX
@article{Kamkong2024,
author = {Kamkong, Jongruk},
title = {The Effect of Hyoscine Butylbromide for Shortening the Active Phase of the First Stage of Labor: A randomized, double-blind, placebo-controlled trial},
journal = {Thai Journal of Obstetrics and Gynaecology},
year = {2024},
doi = {10.14456/tjog.2024.27}
}
EUVIMED